您的位置: 首页 > 农业专利 > 详情页

SYSTÈME D'ADMINISTRATION DE MÉDICAMENT OCULAIRE
专利权人:
LLC;JADE THERAPEUTICS
发明人:
WIROSTKO, BARBARA
申请号:
EP13778272
公开号:
EP2838511A4
申请日:
2013.04.16
申请国别(地区):
EP
年份:
2015
代理人:
摘要:
An ocular drug delivery system including a composition in which a formulation having an active agent such as rHGH and or an rHGH mimic, e.g., that increases insulin growth factor (IGF) or that alters insulin growth factor binding protein (IGFBP) in a subject is dispersed in a pharmaceutical carrier. The composition is configured for placement in, around or on an eye of the subject, and the composition provides controlled release of an amount of the active agent to the eye effective to promote ocular surface and corneal neural regeneration and wound healing.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充